Futura Medical PLC banner

Intrinsic Value

The intrinsic value of Futura Medical PLC (FUM) under the Base Case is 0.369 GBX per share. Compared with the current market price of 0.174 GBX, the stock appears Undervalued by 53% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

FUM Intrinsic Value
0.369 GBX
Undervaluation 53%
Intrinsic Value
Price 0.174 GBX

FUM is cheaper than usual. It was this cheap or cheaper on just 6% of days in the past 5 years.

Monitor FUM
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value 0.3
Get notified when the price drops into your buy zone
Intrinsic Value 0.37
Margin of Safety 20% 0.3
Current Price 0.17
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to FUM

Fundamental Analysis

What Futura Medical Does

Pharmaceuticals Health Care

Futura Medical Plc engages in the development of pharmaceutical and healthcare products. The firm is a developer of sexual health products, including the lead product, Eroxon, and two products in development, including WSD4000 and Eroxon Intense. Eroxon is a clear gel used for the treatment of erectile dysfunction (ED) available over the counter and without prescription and addresses significant unmet needs in the ED market.

Headquarters
United Kingdom UK
Employees
14
IPO date
Jul 10, 2006
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Futura Medical PLC

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one FUM stock?

The intrinsic value for Futura Medical PLC (FUM) under the Base Case is 0.369 GBX.

Is FUM stock undervalued or overvalued?

Compared with the current market price of 0.174 GBX, the stock appears Undervalued by 53% .

Back to Top